Constantine Davides
Stock Analyst at Citizens JMP
(0.08)
# 4,391
Out of 4,442 analysts
184
Total ratings
33.6%
Success rate
-15.1%
Average return
Main Sectors:
Stocks Rated by Constantine Davides
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NRC NRC Health | Initiated Coverage: Buy | $23 | $20.07 | +14.60% | 1 | Jun 22, 2026 | |
| HQY HealthEquity | Maintained: Buy | $122 → $111 | $84.92 | +30.71% | 9 | Jun 1, 2026 | |
| PGNY Progyny | Maintained: Buy | $30 → $31 | $26.63 | +16.41% | 8 | May 11, 2026 | |
| USPH U.S. Physical Therapy | Maintained: Buy | $113 → $98 | $63.50 | +54.33% | 6 | May 8, 2026 | |
| OMDA Omada Health | Maintained: Buy | $18 → $21 | $18.30 | +14.75% | 2 | May 8, 2026 | |
| CCRN Cross Country Healthcare | Downgraded: Hold | n/a | $13.19 | - | 11 | May 7, 2026 | |
| ADUS Addus HomeCare | Maintained: Buy | $150 → $142 | $96.09 | +47.78% | 8 | May 6, 2026 | |
| OPCH Option Care Health | Maintained: Buy | $38 → $32 | $21.97 | +45.65% | 17 | Apr 30, 2026 | |
| AMN AMN Healthcare Services | Maintained: Buy | $22 → $24 | $31.24 | -23.18% | 18 | Feb 23, 2026 | |
| WAY Waystar Holding | Maintained: Buy | $48 → $34 | $18.41 | +84.68% | 3 | Feb 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $11 → $10 | $4.80 | +108.33% | 14 | Jan 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $23 → $24 | $4.54 | +428.63% | 14 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $30 → $31 | $23.74 | +30.58% | 11 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $18.15 | - | 6 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $5.40 | n/a | 7 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $111.73 | n/a | 9 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $25.66 | n/a | 6 | Feb 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $18 | $1.15 | n/a | 1 | May 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $19 | $0.3819 | n/a | 1 | May 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $125 | $0.80 | n/a | 5 | May 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $38.53 | n/a | 3 | May 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $23 | $23.55 | n/a | 4 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5.25 | $1.31 | n/a | 2 | Apr 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $0.0001 | n/a | 3 | Mar 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $8.5 | $2.21 | n/a | 1 | Mar 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $1.21 | n/a | 2 | Mar 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $2.39 | n/a | 2 | Feb 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $50 → $33 | $1.03 | n/a | 3 | Dec 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $68 | $1.38 | n/a | 1 | Oct 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 → $8 | $1.94 | n/a | 2 | Sep 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4.25 | $2.54 | n/a | 1 | Sep 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $2.3 | $0.568 | n/a | 1 | Aug 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $4 | $2.11 | n/a | 1 | Mar 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $41 | $55.92 | n/a | 1 | Sep 27, 2011 |
NRC Health
Jun 22, 2026
Initiated Coverage: Buy
Price Target: $23
Current: $20.07
Upside: +14.60%
HealthEquity
Jun 1, 2026
Maintained: Buy
Price Target: $122 → $111
Current: $84.92
Upside: +30.71%
Progyny
May 11, 2026
Maintained: Buy
Price Target: $30 → $31
Current: $26.63
Upside: +16.41%
U.S. Physical Therapy
May 8, 2026
Maintained: Buy
Price Target: $113 → $98
Current: $63.50
Upside: +54.33%
Omada Health
May 8, 2026
Maintained: Buy
Price Target: $18 → $21
Current: $18.30
Upside: +14.75%
Cross Country Healthcare
May 7, 2026
Downgraded: Hold
Price Target: n/a
Current: $13.19
Upside: -
Addus HomeCare
May 6, 2026
Maintained: Buy
Price Target: $150 → $142
Current: $96.09
Upside: +47.78%
Option Care Health
Apr 30, 2026
Maintained: Buy
Price Target: $38 → $32
Current: $21.97
Upside: +45.65%
AMN Healthcare Services
Feb 23, 2026
Maintained: Buy
Price Target: $22 → $24
Current: $31.24
Upside: -23.18%
Waystar Holding
Feb 18, 2026
Maintained: Buy
Price Target: $48 → $34
Current: $18.41
Upside: +84.68%
Jan 6, 2026
Maintained: Buy
Price Target: $11 → $10
Current: $4.80
Upside: +108.33%
Nov 7, 2025
Maintained: Buy
Price Target: $23 → $24
Current: $4.54
Upside: +428.63%
Nov 7, 2025
Maintained: Buy
Price Target: $30 → $31
Current: $23.74
Upside: +30.58%
Jul 15, 2025
Reiterated: Hold
Price Target: n/a
Current: $18.15
Upside: -
May 6, 2025
Maintained: Hold
Price Target: n/a
Current: $5.40
Upside: n/a
Apr 28, 2025
Reiterated: Hold
Price Target: n/a
Current: $111.73
Upside: n/a
Feb 25, 2025
Maintained: Hold
Price Target: n/a
Current: $25.66
Upside: n/a
May 25, 2023
Initiated Coverage: Buy
Price Target: $18
Current: $1.15
Upside: n/a
May 16, 2023
Maintained: Buy
Price Target: $19
Current: $0.3819
Upside: n/a
May 16, 2023
Reiterated: Buy
Price Target: $125
Current: $0.80
Upside: n/a
May 11, 2023
Reiterated: Buy
Price Target: $15
Current: $38.53
Upside: n/a
May 10, 2023
Reiterated: Buy
Price Target: $23
Current: $23.55
Upside: n/a
Apr 18, 2023
Reiterated: Buy
Price Target: $5.25
Current: $1.31
Upside: n/a
Mar 30, 2023
Reiterated: Buy
Price Target: $6
Current: $0.0001
Upside: n/a
Mar 20, 2023
Initiated Coverage: Buy
Price Target: $8.5
Current: $2.21
Upside: n/a
Mar 16, 2023
Reiterated: Buy
Price Target: $6
Current: $1.21
Upside: n/a
Feb 15, 2023
Reiterated: Buy
Price Target: $15
Current: $2.39
Upside: n/a
Dec 30, 2022
Maintained: Buy
Price Target: $50 → $33
Current: $1.03
Upside: n/a
Oct 18, 2022
Initiated Coverage: Buy
Price Target: $68
Current: $1.38
Upside: n/a
Sep 28, 2022
Maintained: Buy
Price Target: $14 → $8
Current: $1.94
Upside: n/a
Sep 23, 2022
Maintained: Buy
Price Target: $4.25
Current: $2.54
Upside: n/a
Aug 18, 2022
Maintained: Buy
Price Target: $2.3
Current: $0.568
Upside: n/a
Mar 14, 2022
Initiated Coverage: Buy
Price Target: $4
Current: $2.11
Upside: n/a
Sep 27, 2011
Initiated Coverage: Buy
Price Target: $41
Current: $55.92
Upside: n/a